62 y/o M with Stage IVA (T3N2cM0) SCC of the supraglottic larynx arising from the L aryepiglottic fold and invading inner cortex of the thyroid cartilage.
He was treated with definitive chemoradiation using IMRT and concurrent cisplatin. The primary tumor and bilateral involved LNs received 70 Gy in 35 fractions. Entire larynx and high risk neck including bilateral levels II-III and IV on the L received 59.4 Gy in 33 fractions. Low risk elective neck including level IV on the R and upper level II received 54 Gy in 33 fractions.
Also available: ARROCase
Questions? Feedback? Report here